ReviewDiagnostics (Basel, Switzerland)2026
Enhanced Endoscopic Imaging Technologies in Upper Urinary Tract Urothelial Tumors: Implications for Kidney-Sparing Surgery-A Narrative Review.
Review in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Upper tract urothelial carcinoma (UTUC) represents 5-10% of urothelial malignancies and poses significant diagnostic challenges. Ureterorenoscopy (URS) remains essential for definitive diagnosis, tumor characterization, and selection of candidates for kidney-sparing surgery. Recent advances in endoscopic image-enhancement technologies aim to overcome the limitations of conventional white-light URS. The aim of this study is to review the current evidence on advanced endoscopic imaging techniques for the diagnosis and management of UTUC. This narrative literature review summarizes current evidence on advanced endoscopic imaging techniques for UTUC. A comprehensive search of PubMed/MEDLINE, EMBASE, and Scielo databases was conducted to identify studies evaluating photodynamic diagnosis (PDD), narrow band imaging (NBI), Image1-S™-Spies™, optical coherence tomography (OCT), confocal laser endomicroscopy (CLE), and endoluminal ultrasonography (ELUS). Data were qualitatively synthesized by modality. Macroscopic enhancement techniques (PDD, NBI, Image1-S™) improve visualization of urothelial surfaces and vascular patterns during URS. PDD demonstrates the highest diagnostic accuracy, with sensitivities up to 95.8%, and a pooled sensitivity and specificity of 0.96 and 0.86. NBI increases tumor detection rates, identifying up to 22.7% additional lesions in early studies. Microscopic imaging modalities provide complementary information. OCT enables high-resolution cross-sectional imaging with 93% concordance with pathological staging. CLE offers in vivo optical biopsy with near-histological resolution, achieving concordance rates of 100% for low-grade and 83-86% for high-grade tumors. ELUS allows deeper tissue assessment but with lower spatial resolution. Enhanced endoscopic imaging technologies are promising, improving tumor detection, characterization, and intraoperative risk stratification. However, current evidence remains limited and heterogeneous, highlighting the need for large prospective multicenter studies to define their impact on oncological outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.